Related Experiment Videos
Microbial growth in small-volume pharmaceuticals
Abstract:
The ability of aseptically filled pharmaceuticals to support microbial growth was tested on 43 small-volume products (mainly parenterals). These were inoculated with a variety of microorganisms which were known to be associated with contamination of pharmaceutical products. In general, Gram-negative bacteria were found to be much more likely to grow than Gram-positive. It was possible for an inoculum of a few cells to multiply to levels up to 10(7)/mL. The presence of preservatives also influenced the likelihood of growth, 12 out of 19 (63%) of the pharmaceuticals without preservatives supporting growth of one or more microorganisms; only 3 out of 24 (12%) of those with preservatives supported growth. The importance of these observations is discussed with reference to formulation of aseptically filled products, environmental sampling and the quality of cleanroom conditions necessary for production. It is suggested that those pharmaceuticals which are designed to be sterile but not to be terminally sterilized, should be tested before production begins, for their ability to support microbial growth. In this way, the risks involved in aseptically filling can be ascertained. A test is proposed in which "indicator" microorganisms would predict the likelihood of pharmaceutical formulations supporting growth.
Insights
Aseptically filled pharmaceuticals can support microbial growth, especially Gram-negative bacteria. Preservatives significantly reduce this risk, highlighting the need for growth testing in sterile product formulation.
Area of Science:
- Microbiology
- Pharmaceutical Science
- Quality Control
Background:
- Aseptically filled pharmaceuticals require stringent microbial control to ensure sterility.
- Understanding microbial growth potential in parenteral products is crucial for patient safety.
Purpose of the Study:
- To evaluate the microbial growth-supporting capabilities of aseptically filled small-volume pharmaceuticals.
- To assess the impact of preservatives on microbial proliferation in these products.
- To propose a predictive test for microbial growth in pharmaceutical formulations.
Main Methods:
- Testing 43 small-volume pharmaceutical products (parenterals) for microbial growth.
- Inoculating products with common pharmaceutical contaminants (Gram-negative and Gram-positive bacteria).
- Comparing growth in products with and without preservatives.
Main Results:
- Gram-negative bacteria demonstrated higher growth potential than Gram-positive bacteria.
- Microbial populations could increase from a few cells to 10(7)/mL.
- Products without preservatives (63%) were more likely to support growth than those with preservatives (12%).
Conclusions:
- Pharmaceutical formulation and preservative presence significantly influence microbial growth.
- Aseptic processing requires robust environmental monitoring and cleanroom standards.
- Pre-production testing for microbial growth potential is recommended for non-terminally sterilized products.